Zimmer Biomet Company Profile: History, ROSA Robotics, Financials and Stock
Updated: 7 days ago
Zimmer Biomet is an American orthopedic company whose ROSA robots assist surgeons in knee, hip and shoulder replacement. Justin O. Zimmer founded it in 1927 in Warsaw, Indiana; it reported revenue of USD 8.23 billion for 2025. This profile sets out its history, robotics business, figures and listing.
Zimmer Biomet at a Glance
Fact | Detail |
Company | Zimmer Biomet Holdings, Inc. |
Founded | 1927 |
Founder | Justin O. Zimmer |
Headquarters | Warsaw, Indiana, USA |
Employees | About 17,000 in 2024 |
Revenue | USD 8.23 billion, 2025 |
Net income | USD 705 million, 2025 |
Stock listing | NYSE: ZBH |
Chief Executive Officer | Ivan Tornos, since August 2023 |
Company History
Justin O. Zimmer founded the company in 1927 to make aluminium splints. It was later owned by Bristol Myers Squibb, which spun it off in 2001, when it began trading in New York. It acquired Centerpulse in 2003 and completed the purchase of Biomet in 2015, a deal announced the previous year at USD 13.4 billion that created Zimmer Biomet.
Key milestones
1927: Founded.
2001: Spun off and listed.
2003: Centerpulse acquired.
2015: Biomet acquired; ticker changes to ZBH.
July 2016: Medtech, a French surgical robotics company, acquired.
2024: ROSA Shoulder introduced.
ROSA Robotics
The ROSA line comes from Medtech, which Zimmer Biomet bought in July 2016. The portfolio includes ROSA Knee and ROSA Hip, and in 2024 the company introduced ROSA Shoulder, which it describes as the first robotic system for shoulder replacement and the fourth application in the ROSA portfolio.
Financial Performance
Item | 2025 |
Revenue | USD 8.23 billion |
Net income | USD 705 million |
Net margin | About 9% |
Stock Information
Zimmer Biomet trades on the New York Stock Exchange under the ticker ZBH.
Note: this section is general information, not investment advice.
Leadership
Name | Role |
Ivan Tornos | Chief Executive Officer |
Strengths and Challenges
Strengths
A leading position in joint replacement implants.
A robot family that covers knee, hip and shoulder.
Challenges
A competitor with a larger installed base of orthopedic robots.
Slow growth in the core implant market.
Zimmer Biomet FAQ
Is Zimmer Biomet publicly traded?
Yes, on the New York Stock Exchange under the ticker ZBH.
What is ROSA?
Zimmer Biomet's family of surgical robots for knee, hip and shoulder replacement.
Where is Zimmer Biomet based?
In Warsaw, Indiana.
Who is the CEO of Zimmer Biomet?
Ivan Tornos, since August 2023.
When did Zimmer and Biomet merge?
The acquisition of Biomet was completed in 2015.
